Neochromosome, Inc.

NY

UEI
SWR6LN1PSNM5
CAGE
7C0N0
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
45-18 Ct Square W 2Nd Fl, Long Island City, NY 11101, USA
Website
neochromosome.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Synthetic NEO-amplicon production system for high capacity therapeutic gene delivery - neochromosome, INC… R43TR003558 National Center for Advancing Translational Sciences (NIH) $970,224
Plug-and-play HLA for safer and personalized off-the-shelf cell therapies using big-DNA technology R43AI148008 National Institute of Allergy and Infectious Diseases (NIH) $1,200,000
Yeast synthetic biology platform for pathway-level antimicrobial screens R43AI141053 National Institute of Allergy and Infectious Diseases (NIH) $150,000

Quick answers

Is Neochromosome, Inc. registered in SAM.gov?

Yes. Neochromosome, Inc.'s SAM.gov registration is active through February 2, 2027.

What is Neochromosome, Inc.'s most recent federal award?

Neochromosome, Inc.'s most recent federal grant award is Synthetic NEO-amplicon production system for high capacity therapeutic gene delivery - neochromosome, INC… (R43TR003558), from National Center for Advancing Translational Sciences (NIH), on June 15, 2021.

On GovTribe

See Neochromosome, Inc.'s full federal record

  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login